epithalon peptide benefits Peptide: Anti-Aging Epitalon: What can this peptide

Long-Term Safety Unknown Very little information exists regarding prolonged exposure in humans

Cagrilintide, the second generation (2020s) Novo Nordisk took the Pramlintide concept and applied the same half-life extension strategy that they used with Semaglutide: Kept the proline substitutions (anti-amyloid) Added a C20 fatty diacid via a -Glu linker to a lysine residue, albumin binding Additionally stabilized the N- and C-terminal positions Result: Cagrilintide with a half-life of 6.6 days (vs 50 minutes for Pramlintide)

Poor candidates People with complete baldness where follicles have been permanently lost are unlikely to benefit significantly

FEBS Letters